Researchers discover first effective drug to treat rare, genetic liver disease

Researchers from Saint Louis University’s School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that could previously only be treated with a liver transplant. The study, “Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency,” was published online in the New England …

Researchers discover first effective drug to treat rare, genetic liver disease Read More »